Q2 2025 Max Healthcare Institute Ltd Earnings Call Transcript
Key Points
- Max Healthcare Institute Ltd (BOM:543220) reported a strong growth in revenue, with a 22% year-on-year increase and a 10% quarter-on-quarter increase, reaching INR 2,228 crores.
- The company successfully integrated recent acquisitions, Max Lucknow and Max Nagpur, which contributed significantly to the revenue and EBITDA growth.
- The newly operational Max Dwarka Hospital is expected to break even much earlier than anticipated, showcasing efficient management and strategic planning.
- The acquisition of Jaypee Hospital Noida is expected to strengthen the company's presence in the national capital region, with plans to quickly integrate and expand its capacity.
- Max Healthcare Institute Ltd (BOM:543220) continues to expand its capacity with several brownfield and greenfield projects on track, ensuring future growth potential.
- Max Dwarka Hospital reported an EBITDA loss of INR 18 crores, indicating initial operational challenges.
- The company's international patient revenue growth was impacted by political unrest in key markets like Bangladesh and Yemen.
- There are concerns about the potential impact of increased competition in the Noida region, where other hospitals are also expanding.
- The integration and upgrade of Jaypee Hospital Noida will require significant investment, estimated at INR 150-200 crores.
- The company's profitability margins have slightly decreased year-on-year, raising questions about sustaining high margins amidst expansion.
Ladies and gentlemen, good day, and welcome to the Max Healthcare Institute Limited Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Anoop Poojari from CDR India. Thank you, and over to you, sir.
Good afternoon, everyone, and thank you for joining us on Max Healthcare's Q2 and H1 FY25 Earnings Conference Call. We have with us, Mr. Abhay Soi, Chairman and Managing Director; Mr. Yogesh Sareen, Senior Director and Chief Financial Officer; and Mr. Keshav Gupta, Senior Director, Growth, M&A and Business Planning of the company.
We will begin the call with opening remarks from the management, following which we'll have the forum open for an interactive question-and-answer session. Before we start, I would like to point out that some statements made in today's call may be forward-looking in nature, and a disclaimer to this effect has been included in the earnings presentation shared with you earlier. I would now
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
